Apollo Hospitals, a prominent hospital chain in India, has recently announced a groundbreaking partnership to enhance its AI tool for predicting cardiovascular disease risks. Teaming up with Solventum Health Information Systems, a spinoff from 3M, Apollo aims to leverage Solventum’s patient classification and quality methodologies to improve cardiovascular care. The collaboration will involve integrating Solventum’s tools with Apollo’s AI-powered Cardiovascular Disease Risk technology.
The primary focus of this partnership is to assess the effectiveness of their combined solution on population health and resource efficiency metrics. This evaluation will include factors such as mortality rates, lengths of stay, complications, and readmissions. By utilizing diagnosis related groups, case mix index, and severity of illness, the project aims to deliver high-quality care in a cost-effective manner while optimizing resource utilization.
Why is this collaboration significant? Cardiovascular diseases are the leading causes of premature death and morbidity in India, accounting for over a quarter of all deaths in the country. With a severe shortage of cardiologists (one per 250,000 people), predictive analytics play a crucial role in bridging this gap. Enhancing Apollo’s predictive analytics tool will enable the hospital chain to identify high-risk patients more accurately, leading to better outcomes and reduced hospitalizations.
In 2021, Apollo introduced its Cardiovascular Disease Risk tool, which factors in lifestyle attributes and vital signs to predict an individual’s risk of cardiovascular diseases. The following year, the tool was integrated into ConnectedLife, a healthcare application and Fitbit partner in Singapore. Apart from cardiovascular care, Apollo Hospitals has been actively involved in various AI projects. Most notably, the hospital chain is set to adopt AI copilots from Microsoft to support its AI roadmap implementation.
Dr. Sangita Reddy, co-managing director of Apollo Hospitals, expressed optimism about the partnership, stating that it would enable the hospital to deliver timely and personalized care to high-risk patients. Dr. Sandeep Wadhwa, global chief medical officer at Solventum HIS, emphasized the potential for improved patient access, operational efficiency, and clinical outcomes through this collaboration.
In conclusion, the partnership between Apollo Hospitals and Solventum Health Information Systems signifies a significant advancement in cardiovascular care through the integration of predictive analytics and quality methodologies. This collaboration has the potential to revolutionize patient outcomes, reduce complications, and enhance access to high-quality care for individuals in need.
